PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP – Trademark Portfolio
Entity Type: 13
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MIST and MIST THERAPY. The owner is based in NEW YORK, NY.
499 PARK AVENUE, 25TH FLOOR
C/O PERCEPTIVE ADVISORS LLC
NEW YORK, NY 10022
Showing of trademarks Trademarks
Trademark Classifications
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP have?
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 cancelled.
What trademark classes does PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP file in?
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP's most well-known trademarks?
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP's registered trademark portfolio includes well-known marks such as MIST and MIST THERAPY. These are among 3 currently registered trademarks in the portfolio.
What is PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP's trademark registration success rate?
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.